These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33746959)

  • 41. Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp
    Ferreira RC; Castro Dopico X; Oliveira JJ; Rainbow DB; Yang JH; Trzupek D; Todd SA; McNeill M; Steri M; Orrù V; Fiorillo E; Crouch DJM; Pekalski ML; Cucca F; Tree TI; Vyse TJ; Wicker LS; Todd JA
    Front Immunol; 2019; 10():2606. PubMed ID: 31781109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Migratory Properties and Numbers of T Regulatory Cell Subsets in Circulation Are Differentially Influenced by Season and Are Associated With Vitamin D Status.
    Lamikanra AA; Tsang HP; Elsiddig S; Spencer M; Curnow E; Danby R; Roberts DJ
    Front Immunol; 2020; 11():685. PubMed ID: 32508805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients.
    Sthoeger ZM; Sharabi A; Dayan M; Zinger H; Asher I; Sela U; Mozes E
    Hum Immunol; 2009 Mar; 70(3):139-45. PubMed ID: 19280712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO.
    Ye L; Goodall JC; Zhang L; Putintseva EV; Lam B; Jiang L; Liu W; Yin J; Lin L; Li T; Wu X; Yeo G; Shugay M; Chudakov DM; Gaston H; Xu H
    Immunol Cell Biol; 2016 Mar; 94(3):293-305. PubMed ID: 26467610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human CD39
    Magid-Bernstein JR; Rohowsky-Kochan CM
    J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
    Zewdie M; Howe R; Hoff ST; Doherty TM; Getachew N; Tarekegne A; Tessema B; Yamuah L; Aseffa A; Abebe M
    Tuberculosis (Edinb); 2016 Sep; 100():61-68. PubMed ID: 27553411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of tonsillar CD4
    Sumitomo S; Nakachi S; Okamura T; Tsuchida Y; Kato R; Shoda H; Furukawa A; Kitahara N; Kondo K; Yamasoba T; Yamamoto K; Fujio K
    J Autoimmun; 2017 Jan; 76():75-84. PubMed ID: 27653378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
    Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
    Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol.
    Mjösberg J; Svensson J; Johansson E; Hellström L; Casas R; Jenmalm MC; Boij R; Matthiesen L; Jönsson JI; Berg G; Ernerudh J
    J Immunol; 2009 Jul; 183(1):759-69. PubMed ID: 19535629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
    Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
    Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients.
    Zhao C; Chu Y; Liang Z; Zhang B; Wang X; Jing X; Hao M; Wang Y; An J; Zhang X; Sun L; Chen J
    BMC Immunol; 2019 Sep; 20(1):32. PubMed ID: 31484501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
    Sharabi A; Mozes E
    J Immunol; 2008 Sep; 181(5):3243-51. PubMed ID: 18713995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus.
    Lyssuk EY; Torgashina AV; Soloviev SK; Nassonov EL; Bykovskaia SN
    Adv Exp Med Biol; 2007; 601():113-9. PubMed ID: 17712998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD).
    Tan DB; Fernandez S; Price P; French MA; Thompson PJ; Moodley YP
    Immunobiology; 2014 Dec; 219(12):975-9. PubMed ID: 25097153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.
    Aubergeon L; Sawaf M; Felten R; Gottenberg JE; Dumortier H; Monneaux F
    Front Immunol; 2021; 12():767099. PubMed ID: 34899718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
    Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
    Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of FOXP3 in CD4+ CD39+ T cells of patients with systemic lupus erythematosus and dynamic observation of treatment with glucocorticoid].
    Li DM; Li XP; Li XM; Wang GS; Ma Y; Zhao SS; Zheng SG
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1636-8. PubMed ID: 19957514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ex vivo expanded regulatory T cells CD4
    Lifshitz GV; Zhdanov DD; Lokhonina AV; Eliseeva DD; Lyssuck EY; Zavalishin IA; Bykovskaia SN
    Autoimmunity; 2016 Sep; 49(6):388-396. PubMed ID: 27424664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.